Physician

Charles B. Daknis, M.D.

According to 2025 Medicare claims, Charles Daknis, M.D. (NPI: 1891753604) practices pain management in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is SEAVIEW ORTHOPAEDICS & MEDICAL ASSOCIATES LLP (NPI: 1982618757; TIN: 222398304) and primary practice location at 07712-7631.

Daknis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 554 traditional Medicare patients, billed 6,721 HCPCS/CPT codes, and received $236,285 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 1,270 prescription claims across 433 beneficiaries totaling $20,619 in drug costs, led by Lidocaine (Lidocaine). 2022 DME data shows 13 claims. Open Payments data shows 1 records totaling $64. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $68,247 to $20,619. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,523 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	510	8,387	$301,105
2016	520	5,476	$237,074
2017	564	4,343	$253,880
2018	648	4,699	$237,711
2019	617	3,376	$244,069
2020	562	2,763	$197,473
2021	604	3,001	$226,923
2022	603	3,340	$235,460
2023	559	3,539	$241,440
2024	554	6,721	$236,285

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	205	593	$68,247
2016	210	718	$83,138
2017	240	885	$77,188
2018	287	898	$70,027
2019	392	1,100	$62,785
2020	427	1,430	$53,302
2021	423	1,195	$23,218
2022	404	1,194	$30,420
2023	381	1,071	$22,674
2024	433	1,270	$20,619

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	25	$9,640
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	14	$910
2020	17	17	$5,422
2021	16	28	$1,804
2022	13	13	$1,443
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	138	194	$110
64493	Injection of lower or sacral spine facet joint using imaging guidance, single level	72	102	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	432	880	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	343	548	$69
72100	X-ray of lower and sacral spine, 2-3 views	85	86	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lidocaine	Lidocaine	43	1,308	$2,625
Gabapentin	Gabapentin	149	5,717	$1,583
Tizanidine Hcl	Tizanidine Hcl	306	11,125	$1,442
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	109	2,621	$1,183
Diclofenac Sodium	Diclofenac Sodium	66	1,831	$1,027

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$64	Zimmer Biomet Holdings, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles B. Daknis, M.D.?

Tedicare shows public-source Medicare data for Charles B. Daknis, M.D. (NPI 1891753604), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles B. Daknis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles B. Daknis, M.D.?

Charles B. Daknis, M.D. is linked to SEAVIEW ORTHOPAEDICS & MEDICAL ASSOCIATES LLP (billing NPI 1982618757) in the available physician profile data.

Does Charles B. Daknis, M.D. have Open Payments data?

Charles B. Daknis, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.